Abstract:<p>Chemotherapy typically involves the use of specific chemodrugs to inhibit the proliferation of cancer cells, but the frequent emergence of a variety of multidrug‐resistant cancer cells poses a tremendous threat to our combat against cancer. The fundamental causes of multidrug resistance (MDR) have been studied for decades, and can be generally classified into two types: one is associated with the activation of diverse drug efflux pumps, which are responsible for translocating intracellular drug molecules out of the cells; the other is linked with some non‐efflux pump‐related mechanisms, such as antiapoptotic defense, enhanced DNA repair ability, and powerful antioxidant systems. To overcome MDR, intense efforts have been made to develop synergistic therapeutic strategies by introducing MDR inhibitors or combining chemotherapy with other therapeutic modalities, such as phototherapy, gene therapy, and gas therapy, in the hope that the drug‐resistant cells can be sensitized toward chemotherapeutics. In particular, nanotechnology‐based drug delivery platforms have shown the potential to integrate multiple therapeutic agents into one system. In this review, the focus was on the recent development of nanostrategies aiming to enhance the efficiency of chemotherapy and overcome the MDR of cancer in a synergistic manner. Different combinatorial strategies are introduced in detail and the advantages as well as underlying mechanisms of why these strategies can counteract MDR are discussed. This review is expected to shed new light on the design of advanced nanomedicines from the angle of materials and to deepen our understanding of MDR for the development of more effective anticancer strategies.</p><p>This article is categorized under: </p><ul class="plain-list"><li>Nanotechnology Approaches to Biology > Nanoscale Systems in Biology</li><li>Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease</li></ul>

Targeting Drug Delivery Systems for Circumventing Multidrug Resistance of Cancers.

Research Spotlight: Targeting Drug Delivery Systems for Circumventing Multidrug Resistance of Cancers

Advances in Nanobiotechnology-Propelled Multidrug Resistance Circumvention of Cancer

Progress in Research of Nanotherapeutics for Overcoming Multidrug Resistance in Cancer

Nanodelivery Systems as a Novel Strategy to Overcome Treatment Failure of Cancer

Targeted Drug Nanodelivery and Immunotherapy for Combating Tumor Resistance

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Nanomedicines for combating multidrug resistance of cancer

In Vivo Dual-Targeted Chemotherapy of Drug Resistant Cancer by Rationally Designed Nanocarrier.

Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance

Advances in investigations on the mechanism of cancer multidrug resistance and the liposomes-based treatment strategy

Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance

Recent advances in anti-multidrug resistance for nano-drug delivery system

Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology

Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance

Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Dual-Functional Drug Liposomes in Treatment of Resistant Cancers

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery

Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy